关注
Gabriela Kattan Khazanov
Gabriela Kattan Khazanov
Research Psychologist, Philadelphia Veterans Affairs Medical Center
在 sas.upenn.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Social phobia and subtypes in the National Comorbidity Survey–Adolescent Supplement: prevalence, correlates, and comorbidity
M Burstein, JP He, G Kattan, AM Albano, S Avenevoli, KR Merikangas
Journal of the American Academy of Child & Adolescent Psychiatry 50 (9), 870-880, 2011
2972011
Mania with and without depression in a community sample of US adolescents
KR Merikangas, L Cui, G Kattan, GA Carlson, EA Youngstrom, J Angst
Archives of general psychiatry 69 (9), 943-951, 2012
1882012
Is low positive emotionality a specific risk factor for depression? A meta-analysis of longitudinal studies.
GK Khazanov, AM Ruscio
Psychological bulletin 142 (9), 991, 2016
1842016
Changes in positive and negative affect during pharmacological treatment and cognitive therapy for major depressive disorder: a secondary analysis of two randomized controlled …
BD Dunn, RE German, G Khazanov, C Xu, SD Hollon, RJ DeRubeis
Clinical Psychological Science 8 (1), 36-51, 2020
882020
Specific phobia among US adolescents: phenomenology and typology
M Burstein, K Georgiades, JP He, A Schmitz, E Feig, GK Khazanov, ...
Depression and anxiety 29 (12), 1072-1082, 2012
652012
The positive valence systems scale: Development and validation
GK Khazanov, AM Ruscio, CN Forbes
Assessment 27 (5), 1045-1069, 2020
592020
The “Brightening” Effect: Reactions to Positive Events in the Daily Lives of Individuals with Major Depressive Disorder and Generalized Anxiety Disorder
GK Khazanov, AM Ruscio, J Swendsen
Behavior therapy 50 (2), 270-284, 2019
492019
Distress and anhedonia as predictors of depression treatment outcome: A secondary analysis of a randomized clinical trial
GK Khazanov, C Xu, BD Dunn, ZD Cohen, RJ DeRubeis, SD Hollon
Behaviour Research and Therapy 125, 103507, 2020
482020
Anxiety and depression
AM Ruscio, GK Khazanov
The Oxford handbook of mood disorders, 313-324, 2017
352017
Treatment patterns of youth with bipolar disorder: results from the National Comorbidity Survey—Adolescent Supplement (NCS-A)
GK Khazanov, L Cui, KR Merikangas, J Angst
Journal of Abnormal Child Psychology 43, 391-400, 2015
342015
Cognitive and behavioral therapies
ME Thase, G Khazanov, JH Wright
Tasman’s Psychiatry, 1-38, 2023
232023
How well do Cognitive Behavioural Therapy and Behavioural Activation for depression repair anhedonia? A secondary analysis of the COBRA randomized controlled trial
B Alsayednasser, E Widnall, H O'Mahen, K Wright, F Warren, A Ladwa, ...
Behaviour Research and Therapy 159, 104185, 2022
222022
Addressing anhedonia to increase depression treatment engagement
GK Khazanov, CN Forbes, BD Dunn, ME Thase
British Journal of Clinical Psychology 61 (2), 255-280, 2022
192022
Do financial incentives increase mental health treatment engagement? A meta-analysis.
GK Khazanov, PE Morris, A Beed, S Jager-Hyman, K Myhre, JR McKay, ...
Journal of Consulting and Clinical Psychology 90 (6), 528, 2022
172022
Adding cognitive therapy to antidepressant medications decreases suicidal ideation
GK Khazanov, C Xu, SD Hollon, RJ DeRubeis, ME Thase
Journal of affective disorders 281, 183-191, 2021
122021
Stakeholder Perceptions of Lethal Means Safety Counseling: A Qualitative Systematic Review
GK Khazanov, S Keddem, K Hoskins, K Myhre, S Sullivan, E Mitchell, ...
Frontiers in Psychiatry, 2377, 2022
112022
The effectiveness of financial incentives for COVID-19 vaccination: A systematic review
GK Khazanov, R Stewart, MF Pieri, C Huang, CT Robertson, KA Schaefer, ...
Preventive medicine 172, 107538, 2023
72023
Increasing the impact of interventions incentivizing psychiatric treatment engagement: challenges and opportunities
GK Khazanov, SE Forster, D DePhilippis, JR McKay
Psychiatric services 73 (5), 580-583, 2022
52022
Should contingency management protocols and dissemination practices be modified to accommodate rising stimulant use and harm reduction frameworks?
GK Khazanov, JR McKay, R Rawson
Addiction (Abingdon, England), 2024
42024
Validity and reliability of in-person and remote oral fluids drug testing compared to urine drug testing
GK Khazanov, E Ingram, K Lynch, R Trim, J McKay, DW Oslin
Drug and Alcohol Dependence 250, 110876, 2023
42023
系统目前无法执行此操作,请稍后再试。
文章 1–20